hrp0089p2-p040 | Bone, Growth Plate & Mineral Metabolism P2 | ESPE2018
Padidela Raja
, Nilsson Ola
, Linglart Agnes
, Makitie Outi
, Beck-Nielsen Signe
, Ariceta Gema
, Schnabel Dirk
, Brandi Maria Luisa
, Boot Annemieke
, Jandhyala Ravi
, Moeller Gerd
, Levtchenko Elena
, Mughal Zulf
Introduction: X-linked hypophosphatemia (XLH) is a rare, inherited disease that affects approximately 1 in 20,000 individuals. XLH is a disorder of renal phosphate wasting caused by high circulating levels of fibroblast growth factor 23 (FGF23) that impairs normal phosphate reabsorption in the kidney and production of the active form of vitamin D. Children with XLH experience abnormal bone development, rickets, osteomalacia, impaired growth, dental abscesses, craniosynostosis ...